Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Identifieur interne : 000458 ( PubMed/Checkpoint ); précédent : 000457; suivant : 000459Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Auteurs : Jin-Jin Zhang [République populaire de Chine] ; Xiang Dong [République populaire de Chine] ; Yi-Yuan Cao [République populaire de Chine] ; Ya-Dong Yuan [République populaire de Chine] ; Yi-Bin Yang [République populaire de Chine] ; You-Qin Yan [République populaire de Chine] ; Cezmi A. Akdis [Suisse] ; Ya-Dong Gao [République populaire de Chine]Source :
- Allergy [ 1398-9995 ] ; 2020.
Abstract
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been widely spread. We aim to investigate the clinical characteristic and allergy status of patients infected with SARS-CoV-2.
DOI: 10.1111/all.14238
PubMed: 32077115
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:32077115Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.</title><author><name sortKey="Zhang, Jin Jin" sort="Zhang, Jin Jin" uniqKey="Zhang J" first="Jin-Jin" last="Zhang">Jin-Jin Zhang</name><affiliation wicri:level="3"><nlm:affiliation>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Dong, Xiang" sort="Dong, Xiang" uniqKey="Dong X" first="Xiang" last="Dong">Xiang Dong</name><affiliation wicri:level="3"><nlm:affiliation>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Cao, Yi Yuan" sort="Cao, Yi Yuan" uniqKey="Cao Y" first="Yi-Yuan" last="Cao">Yi-Yuan Cao</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Yuan, Ya Dong" sort="Yuan, Ya Dong" uniqKey="Yuan Y" first="Ya-Dong" last="Yuan">Ya-Dong Yuan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Second Hospital of Hebei Medical University, Shijiazhuang, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Respiratory and Critical Care Medicine, Second Hospital of Hebei Medical University, Shijiazhuang</wicri:regionArea><wicri:noRegion>Shijiazhuang</wicri:noRegion></affiliation></author><author><name sortKey="Yang, Yi Bin" sort="Yang, Yi Bin" uniqKey="Yang Y" first="Yi-Bin" last="Yang">Yi-Bin Yang</name><affiliation wicri:level="3"><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Yan, You Qin" sort="Yan, You Qin" uniqKey="Yan Y" first="You-Qin" last="Yan">You-Qin Yan</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Disease, No. 7 Hospital of Wuhan, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Disease, No. 7 Hospital of Wuhan, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Akdis, Cezmi A" sort="Akdis, Cezmi A" uniqKey="Akdis C" first="Cezmi A" last="Akdis">Cezmi A. Akdis</name><affiliation wicri:level="4"><nlm:affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos</wicri:regionArea><orgName type="university">Université de Zurich</orgName><placeName><settlement type="city">Zurich</settlement><region nuts="3" type="region">Canton de Zurich</region></placeName></affiliation></author><author><name sortKey="Gao, Ya Dong" sort="Gao, Ya Dong" uniqKey="Gao Y" first="Ya-Dong" last="Gao">Ya-Dong Gao</name><affiliation wicri:level="3"><nlm:affiliation>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32077115</idno><idno type="pmid">32077115</idno><idno type="doi">10.1111/all.14238</idno><idno type="wicri:Area/PubMed/Corpus">000535</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000535</idno><idno type="wicri:Area/PubMed/Curation">000535</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000535</idno><idno type="wicri:Area/PubMed/Checkpoint">000458</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000458</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.</title><author><name sortKey="Zhang, Jin Jin" sort="Zhang, Jin Jin" uniqKey="Zhang J" first="Jin-Jin" last="Zhang">Jin-Jin Zhang</name><affiliation wicri:level="3"><nlm:affiliation>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Dong, Xiang" sort="Dong, Xiang" uniqKey="Dong X" first="Xiang" last="Dong">Xiang Dong</name><affiliation wicri:level="3"><nlm:affiliation>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Cao, Yi Yuan" sort="Cao, Yi Yuan" uniqKey="Cao Y" first="Yi-Yuan" last="Cao">Yi-Yuan Cao</name><affiliation wicri:level="3"><nlm:affiliation>Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Yuan, Ya Dong" sort="Yuan, Ya Dong" uniqKey="Yuan Y" first="Ya-Dong" last="Yuan">Ya-Dong Yuan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Second Hospital of Hebei Medical University, Shijiazhuang, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Respiratory and Critical Care Medicine, Second Hospital of Hebei Medical University, Shijiazhuang</wicri:regionArea><wicri:noRegion>Shijiazhuang</wicri:noRegion></affiliation></author><author><name sortKey="Yang, Yi Bin" sort="Yang, Yi Bin" uniqKey="Yang Y" first="Yi-Bin" last="Yang">Yi-Bin Yang</name><affiliation wicri:level="3"><nlm:affiliation>Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Yan, You Qin" sort="Yan, You Qin" uniqKey="Yan Y" first="You-Qin" last="Yan">You-Qin Yan</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Disease, No. 7 Hospital of Wuhan, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Disease, No. 7 Hospital of Wuhan, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Akdis, Cezmi A" sort="Akdis, Cezmi A" uniqKey="Akdis C" first="Cezmi A" last="Akdis">Cezmi A. Akdis</name><affiliation wicri:level="4"><nlm:affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos</wicri:regionArea><orgName type="university">Université de Zurich</orgName><placeName><settlement type="city">Zurich</settlement><region nuts="3" type="region">Canton de Zurich</region></placeName></affiliation></author><author><name sortKey="Gao, Ya Dong" sort="Gao, Ya Dong" uniqKey="Gao Y" first="Ya-Dong" last="Gao">Ya-Dong Gao</name><affiliation wicri:level="3"><nlm:affiliation>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author></analytic><series><title level="j">Allergy</title><idno type="eISSN">1398-9995</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been widely spread. We aim to investigate the clinical characteristic and allergy status of patients infected with SARS-CoV-2.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32077115</PMID><DateRevised><Year>2020</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1398-9995</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Allergy</Title><ISOAbbreviation>Allergy</ISOAbbreviation></Journal><ArticleTitle>Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/all.14238</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been widely spread. We aim to investigate the clinical characteristic and allergy status of patients infected with SARS-CoV-2.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Electronic medical records including demographics, clinical manifestation, comorbidities, laboratory data, and radiological materials of 140 hospitalized COVID-19 patients, with confirmed result of SARS-CoV-2 viral infection, were extracted and analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">An approximately 1:1 ratio of male (50.7%) and female COVID-19 patients was found, with an overall median age of 57.0 years. All patients were community-acquired cases. Fever (91.7%), cough (75.0%), fatigue (75.0%), and gastrointestinal symptoms (39.6%) were the most common clinical manifestations, whereas hypertension (30.0%) and diabetes mellitus (12.1%) were the most common comorbidities. Drug hypersensitivity (11.4%) and urticaria (1.4%) were self-reported by several patients. Asthma or other allergic diseases were not reported by any of the patients. Chronic obstructive pulmonary disease (COPD, 1.4%) patients and current smokers (1.4%) were rare. Bilateral ground-glass or patchy opacity (89.6%) was the most common sign of radiological finding. Lymphopenia (75.4%) and eosinopenia (52.9%) were observed in most patients. Blood eosinophil counts correlate positively with lymphocyte counts in severe (r = .486, P < .001) and nonsevere (r = .469, P < .001) patients after hospital admission. Significantly higher levels of D-dimer, C-reactive protein, and procalcitonin were associated with severe patients compared to nonsevere patients (all P < .001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Detailed clinical investigation of 140 hospitalized COVID-19 cases suggests eosinopenia together with lymphopenia may be a potential indicator for diagnosis. Allergic diseases, asthma, and COPD are not risk factors for SARS-CoV-2 infection. Older age, high number of comorbidities, and more prominent laboratory abnormalities were associated with severe patients.</AbstractText><CopyrightInformation>© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jin-Jin</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Yi-Yuan</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Ya-Dong</ForeName><Initials>YD</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Second Hospital of Hebei Medical University, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yi-Bin</ForeName><Initials>YB</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>You-Qin</ForeName><Initials>YQ</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, No. 7 Hospital of Wuhan, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akdis</LastName><ForeName>Cezmi A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Ya-Dong</ForeName><Initials>YD</Initials><AffiliationInfo><Affiliation>Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Allergy</MedlineTA><NlmUniqueID>7804028</NlmUniqueID><ISSNLinking>0105-4538</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">allergy</Keyword><Keyword MajorTopicYN="N">eosinophil</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>02</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>02</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>02</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32077115</ArticleId><ArticleId IdType="doi">10.1111/all.14238</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513.</Citation></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.</Citation></Reference><Reference><Citation>Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. https://doi.org/10.1001/jama.2020.1585 [Epub ahead of print].</Citation></Reference><Reference><Citation>Guan W, Ni Z, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv 2020:2020.02.06.20020974.</Citation></Reference><Reference><Citation>World Health Organization (WHO). Coronavirus disease (COVID-2019) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed February 19, 2020.</Citation></Reference><Reference><Citation>Tan WJ, Zhao X, Ma XJ, et al. A novel coronavirus genome identified in a cluster of pneumonia cases-Wuhan, China 2019-2020. China CDC Weekly. 2020;2:61-62.</Citation></Reference><Reference><Citation>Rambaut A. Preliminary Phylogenetic Analysis of 11 nCoV2019 Genomes, 2020-01-19. http://virological.org/t/preliminary-phylogenetic-analysis-of-11-ncov2019-genomes-2020-01-19/329. Accessed February 12, 2020.</Citation></Reference><Reference><Citation>Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses. 2020;12(2):135.</Citation></Reference><Reference><Citation>Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-523.</Citation></Reference><Reference><Citation>Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2001316 [Epub ahead of print].</Citation></Reference><Reference><Citation>Jackson DJ, Evans MD, Gangnon RE, et al. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med. 2012;185:281-285.</Citation></Reference><Reference><Citation>Rubner FJ, Jackson DJ, Evans MD, et al. Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J Allergy Clin Immunol. 2017;139:501-507.</Citation></Reference><Reference><Citation>Gavala ML, Bertics PJ, Gern JE. Rhinoviruses, allergic inflammation, and asthma. Immunol Rev. 2011;242:69-90.</Citation></Reference><Reference><Citation>Baraldo S, Contoli M, Bazzan E, et al. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J Allergy Clin Immunol. 2012;130:1307-1314.</Citation></Reference><Reference><Citation>Rowe RK, Gill MA. Asthma: the interplay between viral infections and allergic diseases. Immunol Allergy Clin North Am. 2015;35:115-127.</Citation></Reference><Reference><Citation>Gilles S, Blume C, Wimmer M, et al. Pollen exposure weakens innate defense against respiratory viruses. Allergy. 2019. https://doi.org/10.1111/all.14047 [Epub ahead of print].</Citation></Reference><Reference><Citation>Wu YH, Lai AC, Chi PY, et al. Pulmonary IL-33 orchestrates innate immune cells to mediate RSV-evoked airway hyperreactivity and eosinophilia. Allergy. 2019. https://doi.org/10.1111/all.14091 [Epub ahead of print].</Citation></Reference><Reference><Citation>Gavala ML, Bashir H, Gern JE. Virus/allergen interactions in asthma. Curr Allergy Asthma Rep. 2013;13:298-307.</Citation></Reference><Reference><Citation>Holt PG, Strickland DH, Sly PD. Virus infection and allergy in the development of asthma: what is the connection. Curr Opin Allergy Clin Immunol. 2012;12:151-157.</Citation></Reference><Reference><Citation>Leino A, Lukkarinen M, Turunen R, et al. Pulmonary function and bronchial reactivity 4 years after the first virus-induced wheezing. Allergy. 2019;74:518-526.</Citation></Reference><Reference><Citation>Svensson A, Nordström I, Rudin A, Bergström T, Eriksson K. Enveloped virus but not bacteria block IL-13 responses in human cord blood T cells in vitro. Scand J Immunol. 2012;75:409-418.</Citation></Reference><Reference><Citation>Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391:1706-1717.</Citation></Reference><Reference><Citation>Kurai D, Saraya T, Ishii H, Takizawa H. Virus-induced exacerbations in asthma and COPD. Front Microbiol. 2013;4:293.</Citation></Reference><Reference><Citation>Hu SS, Gao RL, Liu LS, et al. Summary of the 2018 report on cardiovascular diseases in China. Chin Circ J. 2019;34:209-220.</Citation></Reference><Reference><Citation>Liu M, Liu SW, Wang LJ, et al. Burden of diabetes, hyperglycaemia in China from to 2016: Findings from the 1990 to 2016, global burden of disease study. Diabetes Metab. 2019;45:286-293.</Citation></Reference><Reference><Citation>Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801-2809.</Citation></Reference><Reference><Citation>Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394:407-418.</Citation></Reference><Reference><Citation>Wang XD, Zheng M, Lou HF, et al. An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011. Allergy. 2016;71:1170-1180.</Citation></Reference><Reference><Citation>Papadopoulos NG, Christodoulou I, Rohde G, et al. Viruses and bacteria in acute asthma exacerbations-a GA2LEN-DARE systematic review. Allergy. 2011;66:458-468.</Citation></Reference><Reference><Citation>Greenberg SB. Update on human rhinovirus and coronavirus infections. Semin Respir Crit Care Med. 2016;37:555-571.</Citation></Reference><Reference><Citation>Zheng XY, Xu YJ, Guan WJ, Lin LF. Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review. Arch Virol. 2018;163:845-853.</Citation></Reference><Reference><Citation>Han M, Rajput C, Ishikawa T, Jarman CR, Lee J, Small HMB. Animal models of respiratory viral infection related to asthma. Viruses. 2018;10(12):682.</Citation></Reference><Reference><Citation>Bønnelykke K, Vissing NH, Sevelsted A, Johnston SL, Bisgaard H. Association between respiratory infections in early life and later asthma is independent of virus type. J Allergy Clin Immunol. 2015;136:81-86.</Citation></Reference><Reference><Citation>Erdem SB, Can D, Girit S, et al. Does atopy affect the course of viral pneumonia. Allergol Immunopathol. 2018;46:119-126.</Citation></Reference><Reference><Citation>World Health Organization (WHO). WHO report on the global tobacco epidemic, 2019 (Country Profile: China). https://www.who.int/tobacco/surveillance/policy/country_profile/chn.pdf?ua=1. Accessed February 17, 2020.</Citation></Reference><Reference><Citation>Seys L, Widagdo W, Verhamme FM, et al. DPP4, the middle east respiratory syndrome coronavirus receptor, is upregulated in lungs of smokers and chronic obstructive pulmonary disease patients. Clin Infect Dis. 2018;66:45-53.</Citation></Reference><Reference><Citation>Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875-879.</Citation></Reference><Reference><Citation>Kuba K, Imai Y, Rao S, Jiang C, Penninger JM. Lessons from SARS: control of acute lung failure by the SARS receptor ACE2. J Mol Med. 2006;84:814-820.</Citation></Reference><Reference><Citation>Kuba K, Imai Y, Penninger JM. Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol. 2006;6:271-276.</Citation></Reference><Reference><Citation>Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020. https://doi.org/10.1007/s11427-020-1637-5 [Epub ahead of print].</Citation></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>République populaire de Chine</li><li>Suisse</li></country><region><li>Canton de Zurich</li><li>Hubei</li></region><settlement><li>Wuhan</li><li>Zurich</li></settlement><orgName><li>Université de Zurich</li></orgName></list><tree><country name="République populaire de Chine"><region name="Hubei"><name sortKey="Zhang, Jin Jin" sort="Zhang, Jin Jin" uniqKey="Zhang J" first="Jin-Jin" last="Zhang">Jin-Jin Zhang</name></region><name sortKey="Cao, Yi Yuan" sort="Cao, Yi Yuan" uniqKey="Cao Y" first="Yi-Yuan" last="Cao">Yi-Yuan Cao</name><name sortKey="Dong, Xiang" sort="Dong, Xiang" uniqKey="Dong X" first="Xiang" last="Dong">Xiang Dong</name><name sortKey="Gao, Ya Dong" sort="Gao, Ya Dong" uniqKey="Gao Y" first="Ya-Dong" last="Gao">Ya-Dong Gao</name><name sortKey="Yan, You Qin" sort="Yan, You Qin" uniqKey="Yan Y" first="You-Qin" last="Yan">You-Qin Yan</name><name sortKey="Yang, Yi Bin" sort="Yang, Yi Bin" uniqKey="Yang Y" first="Yi-Bin" last="Yang">Yi-Bin Yang</name><name sortKey="Yuan, Ya Dong" sort="Yuan, Ya Dong" uniqKey="Yuan Y" first="Ya-Dong" last="Yuan">Ya-Dong Yuan</name></country><country name="Suisse"><region name="Canton de Zurich"><name sortKey="Akdis, Cezmi A" sort="Akdis, Cezmi A" uniqKey="Akdis C" first="Cezmi A" last="Akdis">Cezmi A. Akdis</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000458 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000458 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:32077115
|texte= Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:32077115" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a CovidV1
| This area was generated with Dilib version V0.6.33. |  |